id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
news-007974		Notre Dame Patient Advocacy Initiative receives support from Dyne Therapeutics | News | Notre Dame News | University of Notre Dame			.html	text/html	777	22	33	University of Notre Dame Skip To Content Skip To Navigation Skip To Search University of Notre Dame Notre Dame News Experts ND in the News Subscribe About Us Home Contact Search Menu Home › News › Notre Dame Patient Advocacy Initiative receives support from Dyne Therapeutics Notre Dame Patient Advocacy Initiative receives support from Dyne Therapeutics Published: September 19, 2022 Author: Notre Dame News Main Building Aerial (Photo by Barbara Johnston/University of Notre Dame) Dyne Therapeutics, a leading muscle disease company focused on advancing innovative, life-transforming therapeutics for people living with genetically driven diseases, has made a commitment of $500,000 over five years in support of the University of Notre Dame’s Patient Advocacy Initiative. Posted In: Colleges & Schools Home Experts ND in the News Subscribe About Us Related October 04, 2022 NIH awards $4 million grant to psychologists researching suicide prevention September 27, 2022 Alpha Phi Alpha president to be featured ‘fireside chat’ guest September 16, 2022 School of Architecture to host Notre-Dame Cathedral restoration architects September 16, 2022 Notre Dame Patient Advocacy Initiative receives founding gift from Horizon Therapeutics September 15, 2022 Death penalty abolitionist Sister Helen Prejean to speak at Notre Dame For the Media Contact Office of Public Affairs and Communications Notre Dame News 500 Grace Hall Notre Dame, IN 46556 USA Facebook Twitter Instagram YouTube Pinterest © 2022 University of Notre Dame Search Mobile App News Events Visit Accessibility Facebook Twitter Instagram YouTube LinkedIn	cache/news-007974.html	txt/news-007974.txt